🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
InnoCan Pharma Corporation (CSE:INNO)
Canada flag Canada · Delayed Price · Currency is CAD
1.790
-0.050 (-2.72%)
Nov 19, 2026, 4:44 PM EST

InnoCan Pharma Revenue

InnoCan Pharma had revenue of $5.25M USD in the quarter ending June 30, 2026, a decrease of -25.06%. This brings the company's total for the last twelve months to $23.53M, down -18.39% year-over-year. In the year 2025, InnoCan Pharma had annual revenue of $26.61M, down -9.60%. That makes InnoCan Pharma the 32,941st largest company in the world by revenue and 586th in Canada.

Revenue (ttm)
$23.53M
Revenue Growth
-18.39%
P/S Ratio
0.25
Revenue / Employee
$4.71M
Employees
5
Market Cap
8.50M CAD

Revenue Chart

* This company reports financials in USD.

Revenue by Segment

By Segment

Chart
  • Online Sales 26.60M 99.9%
  • Other Operations 15.00K 0.1%

By Geography

Chart
  • United States 26.60M 99.9%
  • Rest of The World 15.00K 0.1%
Fiscal year ended Dec 31, 2025 See the full InnoCan Pharma breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202526.61M-2.83M-9.60%
Dec 31, 202429.44M15.78M115.55%
Dec 31, 202313.66M11.10M433.69%
Dec 31, 20222.56M2.36M1,205.61%
Dec 31, 2021196.00K188.00K2,350.00%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

InnoCan Pharma News

More News